Related references
Note: Only part of the references are listed.Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity
Viralkumar Davra et al.
CANCER RESEARCH (2021)
Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis
Ievgenia Pastushenko et al.
NATURE (2021)
Modes of Regulated Cell Death in Cancer
Elle Koren et al.
CANCER DISCOVERY (2021)
Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody-Drug Conjugate and Immune Checkpoint Blockade
Julia Boshuizen et al.
CANCER RESEARCH (2021)
TAM Receptor Inhibition-Implications for Cancer and the Immune System
Pia Aehnlich et al.
CANCERS (2021)
Fighting Drug Resistance through the Targeting of Drug-Tolerant Persister Cells
Giulia De Conti et al.
CANCERS (2021)
Circulating Small Extracellular Vesicles Activate TYRO3 to Drive Cancer Metastasis and Chemoresistance
Miso Park et al.
CANCER RESEARCH (2021)
The Role of the Receptor Tyrosine Kinase Axl in Carcinogenesis and Development of Therapeutic Resistance: An Overview of Molecular Mechanisms and Future Applications
Martha Wium et al.
CANCERS (2021)
Small Extracellular Vesicles: A Novel Avenue for Cancer Management
Yanan Gao et al.
FRONTIERS IN ONCOLOGY (2021)
Single-Cell Proteomic Profiling Identifies Combined AXL and JAK1 Inhibition as a Novel Therapeutic Strategy for Lung Cancer
Josephine A. Taverna et al.
CANCER RESEARCH (2020)
ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in EGFR-Mutated Non-Small Cell Lung Cancer
Naoko Okura et al.
CLINICAL CANCER RESEARCH (2020)
Targeting AXL and the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Melanoma
Karine Flem-Karlsen et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Soluble AXL as a marker of disease progression and survival in melanoma
Karine Flem-Karlsen et al.
PLOS ONE (2020)
AXL as a Target in Breast Cancer Therapy
Sierra A. Colavito
JOURNAL OF ONCOLOGY (2020)
Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma
Michael H. Meel et al.
CLINICAL CANCER RESEARCH (2020)
AXL Mediates Cetuximab and Radiation Resistance Through Tyrosine 821 and the c-ABL Kinase Pathway in Head and Neck Cancer
Nellie K. McDaniel et al.
CLINICAL CANCER RESEARCH (2020)
Rac1-dependent phagocytosis of apoptotic cells by oral squamous cell carcinoma cells: A possible driving force for tumor progression
Manabu Yamazaki et al.
EXPERIMENTAL CELL RESEARCH (2020)
Gas6/Axl Signaling Pathway in the Tumor Immune Microenvironment
Mai Tanaka et al.
CANCERS (2020)
EMT, MET, Plasticity, and Tumor Metastasis
Basil Bakir et al.
TRENDS IN CELL BIOLOGY (2020)
Implications of the Receptor Tyrosine Kinase Axl in Gastric Cancer Progression
Lirui He et al.
ONCOTARGETS AND THERAPY (2020)
AXL confers cell migration and invasion by hijacking a PEAK1-regulated focal adhesion protein network
Afnan Abu-Thuraia et al.
NATURE COMMUNICATIONS (2020)
AXL Inactivation Inhibits Mesothelioma Growth and Migration via Regulation of p53 Expression
Wei Song et al.
CANCERS (2020)
Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors
Tuan Zea Tan et al.
EUROPEAN UROLOGY (2019)
Pan-TAM Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti-PD-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer
Canan Kasikara et al.
CANCER RESEARCH (2019)
Axl kinase drives immune checkpoint and chemokine signalling pathways in lung adenocarcinomas
Yoko Tsukita et al.
MOLECULAR CANCER (2019)
EMT and Cancer: More Than Meets the Eye
Rik Derynck et al.
DEVELOPMENTAL CELL (2019)
AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications
Chenjing Zhu et al.
MOLECULAR CANCER (2019)
EMT: A mechanism for escape from EGFR-targeted therapy in lung cancer
Eugene Tulchinsky et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
Non-redundant functions of EMT transcription factors
Marc P. Stemmler et al.
NATURE CELL BIOLOGY (2019)
EMT Transition States during Tumor Progression and Metastasis
Ievgenia Pastushenko et al.
TRENDS IN CELL BIOLOGY (2019)
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
Hirokazu Taniguchi et al.
NATURE COMMUNICATIONS (2019)
A TAZ-AXL-ABL2 Feed-Forward Signaling Axis Promotes Lung Adenocarcinoma Brain Metastasis
Jacob P. Hoj et al.
CELL REPORTS (2019)
Epithelial-to-mesenchymal transition: lessons from development, insights into cancer and the potential of EMT-subtype based therapeutic intervention
Jane Antony et al.
PHYSICAL BIOLOGY (2019)
p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenografts
Kathryn A. Mills et al.
SCIENTIFIC REPORTS (2019)
Subtypes of tumour cell-derived small extracellular vesicles having differently externalized phosphatidylserine
Sachiko Matsumura et al.
JOURNAL OF EXTRACELLULAR VESICLES (2019)
Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
Hirokazu Sadahiro et al.
CANCER RESEARCH (2018)
ATP-binding cassette member B5 (ABCB5) promotes tumor cell invasiveness in human colorectal cancer
Qin Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Discovery of N-[4-(Quinolin-4-yloxy)phenyl]benzenesulfonamides as Novel AXL Kinase Inhibitors
Istvan Szabadkai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Targeting Gas6/TAM in cancer cells and tumor microenvironment
Guiling Wu et al.
MOLECULAR CANCER (2018)
Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors
Julia Boshuizen et al.
NATURE MEDICINE (2018)
The molecular basis of JAK/STAT inhibition by SOCS1
Nicholas P. D. Liau et al.
NATURE COMMUNICATIONS (2018)
The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression
Marie-Anne Goyette et al.
CELL REPORTS (2018)
HGF-induced formation of the MET-AXL-ELMO2-DOCK180 complex promotes RAC1 activation, receptor clustering, and cancer cell migration and invasion
Wenjing Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Transcriptional upregulation of c-MYC by AXL confers epirubicin resistance in esophageal adenocarcinoma
Jun Hong et al.
MOLECULAR ONCOLOGY (2018)
Sitravatinib potentiates immune checkpoint blockade in refractory cancer models
Wenting Du et al.
JCI INSIGHT (2018)
Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer
Kathleen F. Ludwig et al.
CANCER RESEARCH (2018)
Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis
Wilhem Leconet et al.
CLINICAL CANCER RESEARCH (2017)
Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies
Mihalis S. Kariolis et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape
Malte Mohme et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Regulated intramembrane proteolysis of the AXL receptor kinase generates an intracellular domain that localizes in the nucleus of cancer cells
Yinzhong Lu et al.
FASEB JOURNAL (2017)
TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy
Yemsratch T. Akalu et al.
IMMUNOLOGICAL REVIEWS (2017)
Activated Microglia Desialylate and Phagocytose Cells via Neuraminidase, Galectin-3, and Mer Tyrosine Kinase
Koji Nomura et al.
JOURNAL OF IMMUNOLOGY (2017)
Genome-wide screen of gamma-secretase-mediated intramembrane cleavage of receptor tyrosine kinases
Johannes A. M. Merilahti et al.
MOLECULAR BIOLOGY OF THE CELL (2017)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
AXL and MET receptor tyrosine kinases are essential for lung cancer metastasis
Yun Jung Choi et al.
ONCOLOGY REPORTS (2017)
The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor
Toni M. Brand et al.
SCIENCE SIGNALING (2017)
Axl inhibition induces the antitumor immune response which can be further potentiated by PD-1 blockade in the mouse cancer models
Zhiqiang Guo et al.
ONCOTARGET (2017)
Gas6 derived from cancer-associated fibroblasts promotes migration of Axl-expressing lung cancer cells during chemotherapy
Ryu Kanzaki et al.
SCIENTIFIC REPORTS (2017)
The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor
Toni M. Brand et al.
SCIENCE SIGNALING (2017)
Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models
Pinar Kanlikilicer et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma
Carmela Dantas-Barbosa et al.
BRITISH JOURNAL OF CANCER (2017)
Targeting AXL and mTOR Pathway Overcomes Primary and Acquired Resistance to WEE1 Inhibition in Small-Cell Lung Cancer
Triparna Sen et al.
CLINICAL CANCER RESEARCH (2017)
AXL-Driven EMT State as a Targetable Conduit in Cancer
Jane Antony et al.
CANCER RESEARCH (2017)
Molecular Pathways: Oncologic Pathways and Their Role in T-cell Exclusion and Immune Evasion-A New Role for the AXL Receptor Tyrosine Kinase
Todd A. Aguilera et al.
CLINICAL CANCER RESEARCH (2017)
Engulfment signals and the phagocytic machinery for apoptotic cell clearance
Seung-Yoon Park et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective
Samuel H. Myers et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
Hetero-interaction amongst Tyro3 and Axl receptor tyrosine kinases diversifies cancer signalling
M. Vouri et al.
EUROPEAN JOURNAL OF CANCER (2016)
4-Oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as New Axl Kinase Inhibitors
Li Tan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer
Jane Antony et al.
SCIENCE SIGNALING (2016)
Reprogramming the immunological microenvironment through radiation and targeting Axl
Todd A. Aguilera et al.
NATURE COMMUNICATIONS (2016)
ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types
Waltraut Lehmann et al.
NATURE COMMUNICATIONS (2016)
AXL modulates extracellular matrix protein expression and is essential for invasion and metastasis in endometrial cancer
Laura M. Divine et al.
ONCOTARGET (2016)
Gas6/Axl Axis Contributes to Chemoresistance and Metastasis in Breast Cancer through Akt/GSK-3 beta/beta-catenin Signaling
Cun Wang et al.
THERANOSTICS (2016)
The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer
Jane Antony et al.
SCIENCE SIGNALING (2016)
AXL Mediates Resistance to PI3Kα Inhibition by Activating the EGFR/PKC/mTOR Axis in Head and Neck and Esophageal Squamous Cell Carcinomas
Moshe Elkabets et al.
CANCER CELL (2015)
ΔNp63α Promotes Breast Cancer Cell Motility through the Selective Activation of Components of the Epithelial-to-Mesenchymal Transition Program
Tuyen T. Dang et al.
CANCER RESEARCH (2015)
Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis
Amanda Kirane et al.
CANCER RESEARCH (2015)
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
Xiaofeng Zheng et al.
NATURE (2015)
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
Kari R. Fischer et al.
NATURE (2015)
Mesenchymal Cancer Cell-Stroma Crosstalk Promotes Niche Activation, Epithelial Reversion, and Metastatic Colonization
Yaiza del Pozo Martin et al.
CELL REPORTS (2015)
Axl Phosphorylates Elmo Scaffold Proteins To Promote Rac Activation and Cell Invasion
Afnan Abu-Thuraia et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
FRA-1 as a driver of tumour heterogeneity: a nexus between oncogenes and embryonic signalling pathways in cancer
A. S. Dhillon et al.
ONCOGENE (2015)
Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
Woonyoung Choi et al.
CANCER CELL (2014)
Overexpression of MERTK Receptor Tyrosine Kinase in Epithelial Cancer Cells Drives Efferocytosis in a Gain-of-Function Capacity
Khanh-Quynh N. Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells
Magdalena Paolino et al.
NATURE (2014)
An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis
Mihalis S. Kariolis et al.
NATURE CHEMICAL BIOLOGY (2014)
Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival
S. Ammoun et al.
ONCOGENE (2014)
Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET
Erinn B. Rankin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Axl gene knockdown inhibits the metastasis properties of hepatocellular carcinoma via PI3K/Akt-PAK1 signal pathway
Jingchao Xu et al.
TUMOR BIOLOGY (2014)
Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities
Erin D. Lew et al.
ELIFE (2014)
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
Douglas K. Graham et al.
NATURE REVIEWS CANCER (2014)
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer
Tuan Zea Tan et al.
EMBO MOLECULAR MEDICINE (2013)
HGF induces novel EGFR functions involved in resistance formation to tyrosine kinase inhibitors
S. Gusenbauer et al.
ONCOGENE (2013)
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
M. Angela Nieto
SCIENCE (2013)
The Receptor AXL Diversifies EGFR Signaling and Limits the Response to EGFR-Targeted Inhibitors in Triple-Negative Breast Cancer Cells
Aaron S. Meyer et al.
SCIENCE SIGNALING (2013)
Biology of the TAM Receptors
Greg Lemke
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Axl is essential for VEGF-A-dependent activation of PI3K/Akt
Guo-Xiang Ruan et al.
EMBO JOURNAL (2012)
Galectin-3 is a new MerTK-specific eat-me signal
Nora B. Caberoy et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhenfeng Zhang et al.
NATURE GENETICS (2012)
Genetic Dissection of TAM Receptor-Ligand Interaction in Retinal Pigment Epithelial Cell Phagocytosis
Tal Burstyn-Cohen et al.
NEURON (2012)
Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL
A. E. Sayan et al.
ONCOGENE (2012)
Prolonged Exposure to a Mer Ligand in Leukemia: Gas6 Favors Expression of a Partial Mer Glycoform and Reveals a Novel Role for Mer in the Nucleus
Justine Migdall-Wilson et al.
PLOS ONE (2012)
Cross-Phosphorylation, Signaling and Proliferative Functions of the Tyro3 and Axl Receptors in Rat2 Cells
Jessica E. Brown et al.
PLOS ONE (2012)
Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA
Mark Mackiewicz et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions
Helge Siemens et al.
CELL CYCLE (2011)
AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma
M. Z. Xu et al.
ONCOGENE (2011)
Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer
G. Mudduluru et al.
ONCOGENE (2011)
TAM receptors and the clearance of apoptotic cells
Greg Lemke et al.
CLEARANCE OF DYING CELLS IN HEALTHY AND DISEASED IMMUNE SYSTEMS (2010)
AXL Is an Essential Factor and Therapeutic Target for Metastatic Ovarian Cancer
Erinn B. Rankin et al.
CANCER RESEARCH (2010)
R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer
Sacha J. Holland et al.
CANCER RESEARCH (2010)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
TAM receptor signaling and autoimmune disease
Carla V. Rothlin et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Tubby and tubby-like protein 1 are new MerTK ligands for phagocytosis
Nora B. Caberoy et al.
EMBO JOURNAL (2010)
Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood
C. Ekman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies
X. Ye et al.
ONCOGENE (2010)
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
Christine Gjerdrum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis
Y. Li et al.
ONCOGENE (2009)
GEF what?: Dock 180 and related proteins help Rac to polarize cells in new ways
Jean-Francois Cote et al.
TRENDS IN CELL BIOLOGY (2007)
Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells
Heather M. Seitz et al.
JOURNAL OF IMMUNOLOGY (2007)
Opposite effects of Rho family GTPases on engulfment of apoptotic cells by macrophages
M Nakaya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Structural basis for Gas6-Axl signalling
T Sasaki et al.
EMBO JOURNAL (2006)
Aminophospholipid asymmetry: A matter of life and death
K Balasubramanian et al.
ANNUAL REVIEW OF PHYSIOLOGY (2003)
Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family
QX Lu et al.
SCIENCE (2001)
Danger signals: SOS to the immune system
S Gallucci et al.
CURRENT OPINION IN IMMUNOLOGY (2001)
Share Paper
